$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Hepatolithiasis refers to stones located in the bile ducts branching above the confluence of the right and left hepatic ducts. These stones can cause bile duct obstruction, leading to impaired bile drainage and symptoms such as abdominal pain, fever, and jaundice (yellowing of the skin and sclera). Chronic hepatolithiasis may result in serious complications, including biliary cirrhosis, hepatic atrophy, and other liver lesions. Currently, the primary treatment for hepatolithiasis involves surgical interventions such as choledochotomy, hepatectomy, and laparoscopic choledochotomy. However, these procedures are associated with significant trauma and prolonged recovery periods, posing challenges, particularly for physically weaker patients1,2.
With the advancement of minimally invasive techniques, endoscopic retrograde cholangiopancreatography (ERCP) has proven effective for managing extrahepatic bile duct stones. It can also address some extrahepatic stones extending into the intrahepatic ducts or intrahepatic stones located near the hilum. During ERCP, stones are removed using an endoscope that is introduced through the mouth and navigates through the duodenal papilla into the bile ducts. This minimally invasive approach avoids traditional surgery, reduces patient suffering, and minimizes physical disruption. However, ERCP is not without challenges, particularly in achieving selective cannulation of the target intrahepatic bile ducts3,4,5.
In this article, we present the case of a 37-year-old female patient with recurrent hepatolithiasis who underwent ERCP facilitated by a novel disposable ultrafine peroral cholangioscope. The goal of this protocol is to illustrate the technical approach, clinical safety, and outcomes of peroral cholangioscopy-assisted ERCP in the management of hepatolithiasis.